Ozanimod Hydrochloride API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: Supplied to an in-house or pharmacopoeial specification
Reference Brands: Zeposia
Category: Active Pharmaceutical Ingredient
Ozanimod hydrochloride is an oral S1P receptor modulator used in multiple sclerosis and ulcerative colitis. It is sourced by formulation manufacturers, CDMOs and R&D teams.
Manufacture or export Ozanimod Hydrochloride API? List it or send an offer →
Product Description:
Ozanimod is a sphingosine-1-phosphate receptor modulator that binds the S1P1 and S1P5 subtypes and keeps lymphocytes in the lymph nodes, reducing the number that reach sites of inflammation. It is approved for adults with relapsing forms of multiple sclerosis, including clinically isolated syndrome, relapsing-remitting disease and active secondary progressive disease, and for adults with moderately to severely active ulcerative colitis (reference brand: Zeposia).
Specification at a glance
| Traded form | Monohydrochloride of the (S)-enantiomer; white to off-white solid, freely soluble in water and alcohol |
|---|---|
| CAS number | 1618636-37-5 |
| Molecular formula | C23H24N4O3·HCl |
| Molecular weight | 440.92 g/mol |
| Pharmacopoeia | No pharmacopoeia monograph found in USP, Ph. Eur., JP, BP or IP (unverified); supplied to an in-house specification. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 4 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (2033). European Union: Protected beyond 2033 (2034).
Handling and quality points
Ozanimod contains a secondary amine, which puts nitrosamine drug substance-related impurities (NDSRIs) near the top of any supplier review: ask for the risk assessment, test data and the controls on nitrite in reagents and solvents. It is a single (S)-enantiomer, so chiral purity must be specified. It is active at low exposure and is often handled as a high-potency compound under containment.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Ozanimod Hydrochloride API — third party manufacturing & bulk supply
Ozanimod Hydrochloride API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Ozanimod Hydrochloride API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Ozanimod Hydrochloride API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Ozanimod Hydrochloride API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Buyers usually ask for the GMP certificate, certificate of analysis, specification and a US DMF letter of access or EU ASMF for filings. For this molecule a detailed nitrosamine risk assessment, with test results for the specific N-nitroso impurity, is essential. Chiral purity data and stability results are the other common requests.
The hydroxyethylamino group on the indane ring is a secondary amine, which can react with nitrites to form an N-nitroso derivative. Regulators expect a structure-specific risk assessment and, where needed, a validated method and limit for that impurity, so ask for both before choosing a source.
Yes. We introduce licensed formulators, CDMOs and research teams to GMP-compliant producers of ozanimod hydrochloride after checking their documentation. Your details are shared only once both sides are happy to proceed.
Related Products
Encorafenib API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Braftovi
View DetailsRelugolix API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Orgovyx, Myfembree, Ryeqo
View DetailsVenetoclax API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Venclexta, Venclyxto
View DetailsLumacaftor API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Orkambi
View DetailsAmyl Nitrite
Strength:
Purity 99%
Form: Clear, yellowish volatile liquid with fruity odor
Reference Brands:
View DetailsGadobenic Acid
Strength:
Supplied as high-purity API powder
Form: White to off-white crystalline powder
Reference Brands: MultiHance (US/EU)
View DetailsEfinaconazole
Strength:
Standard commercial purity ranges 98% (HPLC)
Form: White to beige crystalline powder
Reference Brands: Jublia (US)
View DetailsAmiodarone
Strength:
Assay 98.5–101.0% (USP/EP Standard )
Form: fine white powder
Reference Brands: Cordarone (US/EU)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit